Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diagnostic lessons in Sudan ebola success:

This article was originally published in Clinica

Executive Summary

The World Health Organization is attributing the successful containment and eradication of Sudan's ebola haemorrhagic fever (EHF) outbreak to improved detection methods and response capacity at local levels. The outbreak - the fifth in Sudan in as many years - was declared over on August 7, which was 42 days (twice the disease's incubation period) after the last of only seven fatalities. The success of the Yambio-centred campaign lies in the high disease detection and containment rates. The Sudanese authorities were backed by specialised international assistance in the form of virus-typing and specialised testing performed by the Kenyan Medical Research Institute and the US Centers for Disease Control and Prevention.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel